Christoph Antz
Tracked across 7 events · 45 articles · First seen Jul 06, 2026 · Last active Sep 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
VERAXA Biotech AG AG, a developer of next-generation antibody-based cancer therapies, announced the appointment of Raju Willener as Chief Financial Officer, effective immediately. Willener, who brings over three decades of experience in global capital markets…
Impact: As CEO, welcomed the new CFO and will oversee his integration into the leadership team.
Sep 04, 2026 · 6 articles
Business
Impact: As CEO and Co-Founder of VERAXA, Christoph Antz announced the collaboration and expressed optimism about AI integration in drug development.
Jul 13, 2026 · 7 articles
Business
Impact: CEO Christoph Antz is quoted providing strategic direction and confidence in the BiTAC platform.
Jul 06, 2026 · 7 articles
Business
Impact: Christoph Antz, CEO and Co-Founder, commented on the patent developments, emphasizing the importance of IP strategy for the company.
Jul 29, 2026 · 6 articles
Business
Impact: As CEO and Co-Founder, Antz is listed as a contact but not directly involved in the EGM proceedings.
Jul 24, 2026 · 6 articles
Tech
Impact: Christoph Antz, CEO of VERAXA, is listed as a contact but not directly involved in the event's actions.
Aug 24, 2026 · 6 articles
Regulatory
Impact: Christoph Antz is CEO of VERAXA, but is not directly quoted or involved in this specific announcement.
Jul 20, 2026 · 7 articles
VERAXA Biotech AG
ceo
↔
Christoph Antz
Christoph Antz is the Chief Executive Officer and Co-Founder of VERAXA Biotech A
ERGEN INTELLIGENCE
Track Christoph Antz live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard